News & Blog
Bad neighbors: Human settlement and climate change are stressing Kenya’s elephants.
Antioxidants and HIV: GSH Pathways Improve Patient Immune Health
Additional Results
Assay Consulting Services
…enzyme. Arbor Assays will not develop ELISAs to infectious antigens. Experienced with almost every detection and solid phase technology available, including enzyme and chemically generated colorimetric, fluorescent, chemiluminescent and bioluminescent…
Read MoreCustom Assay Development
…the sample specific to that antigen binds and is then detected using a secondary antibody labeled with enzyme. Experienced with almost every detection and solid phase technology available, including enzyme…
Read MoreServices
…molecule in the sample or the molecule labeled with enzyme onto a solid phase. Learn More ELISA Assay Development Where an antigen is immobilized on the solid phase and antibody…
Read MoreRare Reagent Generation
…the generation of high quality polyclonal and monoclonal antibodies as well as suitable enzyme and luminescent detection conjugates for immunoassay use. Under our direction, the high quality, chemical organic synthesis…
Read MorePublication: New insights into selective PDE4D inhibitors: 3-(Cyclopentyloxy)-4-methoxybenzaldehyde O-(2-(2,6-dimethylmorpholino)-2-oxoethyl) oxime (GEBR-7b) structural development and promising activities to restore memory impairment
Read More
Publication: A G-quadruplex stabilizer, CX-5461 combined with two immune checkpoint inhibitors enhances in vivo therapeutic efficacy by increasing PD-L1 expression in colorectal cancer
Read More
Publication: Intracellular sites of AQP2 S256 phosphorylation identified using inhibitors of the AQP2 recycling itinerary
Read More
Publication: Novel, Brain-Permeable, Cross-Species Benzothiazole Inhibitors of Microsomal Prostaglandin E Synthase-1 (mPGES-1) Dampen Neuroinflammation In Vitro and In Vivo
Read More
Publication: “Clicking” fragment leads to novel dual-binding cholinesterase inhibitors”
Read More
Publication: Synthesis, biological activities and pharmacokinetic properties of new fluorinated derivatives of selective PDE4D inhibitors
Read More
Publication: Nuclear factor-kappaB (NF-kappaB) mediates a protective response in cancer cells treated with inhibitors of fatty acid synthase
Read More